A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting ...
Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
The agency’s new guidelines are created to eliminate pharmaceutical company practices that minimize or distract consumers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback